Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease; ABO-401 for the treatment of cystic fibrosis; and ABO-50X for the treatment of genetic eye disorders. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was incorporated in 1974 and is headquartered in New York, New York.. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Abeona Therapeutics Inc..
Abeona Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Abeona Therapeutics Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Abeona Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Abeona Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Abeona Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of Abeona Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
NA
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Abeona Therapeutics Inc.- Key Facts
2.2 Abeona Therapeutics Inc.- Geographic Locations
2.3 Abeona Therapeutics Inc.- Subsidiaries and Affiliates
2.4 Abeona Therapeutics Inc.- Business Divisions
2.5 Abeona Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Abeona Therapeutics Inc. Strategic Analysis Review
3.1 Abeona Therapeutics Inc.- Key Strategies
3.2 Abeona Therapeutics Inc.- Company Outlook Statement
3.3 Abeona Therapeutics Inc.- SWOT Analysis
3.3.1 Abeona Therapeutics Inc.- Key Strengths
3.3.2 Abeona Therapeutics Inc.- Key Weaknesses
3.3.3 Abeona Therapeutics Inc.- Potential Opportunities
3.3.4 Abeona Therapeutics Inc.- Potential Threats
3.4 Abeona Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 Abeona Therapeutics Inc.- Business Overview
4.2 Abeona Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 Abeona Therapeutics Inc.- Key Products
5.2 Abeona Therapeutics Inc.- Key Service Areas
5.3 Abeona Therapeutics Inc.- Key Brands
6 Company Developments
6.1 Abeona Therapeutics Inc.- Company History
6.2 Abeona Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 Abeona Therapeutics Inc.- Income Statements
7.2 Abeona Therapeutics Inc.- Balance Sheet
7.3 Abeona Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Abeona Therapeutics Inc.- Direct Competitors
8.2 Abeona Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 Abeona Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 Abeona Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
NA
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!